Weighing Risks Vs. Benefits of Systemic AD Treatments
The Dermatology Digest
FEBRUARY 26, 2024
Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the biologics).
Let's personalize your content